Addison Advisors LLC Increases Stake in Colgate-Palmolive (NYSE:CL)

Addison Advisors LLC boosted its position in shares of Colgate-Palmolive (NYSE:CL) by 5.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 3,365 shares of the company’s stock after purchasing an additional 168 shares during the quarter. Addison Advisors LLC’s holdings in Colgate-Palmolive were worth $268,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. &PARTNERS grew its position in Colgate-Palmolive by 0.7% during the 4th quarter. &PARTNERS now owns 17,643 shares of the company’s stock valued at $1,406,000 after purchasing an additional 129 shares during the last quarter. West Branch Capital LLC lifted its stake in Colgate-Palmolive by 24.0% during the 4th quarter. West Branch Capital LLC now owns 682 shares of the company’s stock valued at $54,000 after acquiring an additional 132 shares during the period. First Foundation Advisors lifted its stake in Colgate-Palmolive by 2.7% during the 3rd quarter. First Foundation Advisors now owns 5,226 shares of the company’s stock valued at $372,000 after acquiring an additional 136 shares during the period. Waldron Private Wealth LLC lifted its stake in Colgate-Palmolive by 2.7% during the 3rd quarter. Waldron Private Wealth LLC now owns 5,361 shares of the company’s stock valued at $381,000 after acquiring an additional 140 shares during the period. Finally, Autumn Glory Partners LLC lifted its stake in Colgate-Palmolive by 2.7% during the 4th quarter. Autumn Glory Partners LLC now owns 5,319 shares of the company’s stock valued at $424,000 after acquiring an additional 140 shares during the period. 80.41% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms have issued reports on CL. StockNews.com cut shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, February 20th. Citigroup increased their price objective on shares of Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, April 16th. Evercore ISI upped their price target on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a research report on Monday, April 8th. TheStreet raised shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a research note on Friday, January 26th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the company an “overweight” rating in a research note on Thursday, January 18th. Three analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $89.50.

Colgate-Palmolive Price Performance

CL stock traded up $1.72 during midday trading on Friday, hitting $91.01. The company’s stock had a trading volume of 7,541,541 shares, compared to its average volume of 3,968,951. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $92.25. The company has a quick ratio of 0.71, a current ratio of 1.11 and a debt-to-equity ratio of 8.59. The firm has a market capitalization of $74.81 billion, a price-to-earnings ratio of 32.74, a price-to-earnings-growth ratio of 3.35 and a beta of 0.42. The company has a 50 day moving average of $87.66 and a two-hundred day moving average of $81.46.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.82 by $0.04. The business had revenue of $5.07 billion for the quarter, compared to analysts’ expectations of $4.96 billion. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The company’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.73 EPS. On average, analysts expect that Colgate-Palmolive will post 3.5 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.20%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date of this dividend is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio is 71.94%.

Insider Transactions at Colgate-Palmolive

In other news, Director C Martin Harris sold 2,760 shares of the company’s stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $84.50, for a total transaction of $233,220.00. Following the sale, the director now directly owns 19,272 shares of the company’s stock, valued at approximately $1,628,484. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, EVP Gregory Malcolm sold 8,930 shares of the stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $85.35, for a total transaction of $762,175.50. Following the sale, the executive vice president now owns 8,043 shares in the company, valued at approximately $686,470.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director C Martin Harris sold 2,760 shares of the stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total value of $233,220.00. Following the sale, the director now owns 19,272 shares in the company, valued at approximately $1,628,484. The disclosure for this sale can be found here. Insiders have sold 232,371 shares of company stock valued at $19,505,099 in the last ninety days. Corporate insiders own 0.34% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.